Clinical Trial Update: A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 study evaluating cyclophosphamide/methotrexate/5-fluorouracil (CMF) with pegfilgrastim in breast cancer patients; the trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adrucil (5-fluorouracil)
• Cytoxan (cyclophosphamide)
• NEULASTA (pegfilgrastim)
• Trexall (Methotrexate)

Snippet

Sponsor: Amgen | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED